Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

elanco malaysia sdn bhd - ciclosporin/cyclosporin -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

elanco malaysia sdn bhd - ciclosporin/cyclosporin -

United States - English - NLM (National Library of Medicine)

vetrimax veterinary products, llc - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - for veterinary use only. atopicream hc™ provides temporary relief of itching, skin irritation and rashes due to allergic response, contact allergens and insect bites. atopicream hc™ contains hydrocortisone to reduce itching and other ingredients including ceramides that promote healthy skin regeneration in animals.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

axichem pty ltd - tralkoxydim - water dispersible granule - tralkoxydim cyclohexanediones active 400.0 g/kg - herbicide - barley | barley - see label for exceptions | cereal rye | triticale | wheat - annual or wimmera ryegrass | annual phalaris | lesser canary grass - suppression | paradoxa grass - suppression | wild oat | canary grass | rigid ryegrass | wimmera ryegrass

European Union - English - EMA (European Medicines Agency)

almirall, s.a. - lebrikizumab - dermatitis, atopic - other dermatological preparations - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

organon laboratories limited - dexamethasone nandrolone decanoate chlorhexidine hydrochloride - cream

New Zealand - English - Ministry for Primary Industries

elanco australasia pty ltd - cyclosporin a. - cyclosporin a. 100 g/litre - immunomodulator

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agents for dermatitis, excluding corticosteroids - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy.children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy.asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5.1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment.children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment.chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control.prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy.eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

elanco gmbh - ciclosporin - capsule, soft - 10 milligrams per capsule - zzz ciclosporin

Ireland - English - HPRA (Health Products Regulatory Authority)

elanco gmbh - ciclosporin - capsule, soft - 100.00 milligrams per capsule - zzz ciclosporin